Physician profile
Luchane C Boyd
NPI 1699572230
$1,805.72
in general payments reported to CMS, 2019-2025
20 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $291.52 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $235.58 | 2025 | Breztri |
| Amgen INC. | $161.94 | 2025 | Uplizna |
| Teva Pharmaceuticals USA, INC. | $151.14 | 2025 | Austedo Xr |
| Alexion Pharmaceuticals, INC. | $134.78 | 2025 | |
| Emd Serono, INC. | $119.23 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $119.18 | 2025 | Rexulti |
| Tactile Systems Technology INC | $116.33 | 2025 | Flexitouch Plus, Nimbl |
| Neurocrine Biosciences, INC. | $75.49 | 2025 | |
| Corcept Therapeutics | $67.78 | 2025 | Korlym |
| Lundbeck LLC | $67.00 | 2025 | Vyepti |
| Genentech USA, INC. | $58.07 | 2025 | Ocrevus Zunovo |
| Ucb, INC. | $35.00 | 2025 | Rystiggo |
| Ani Pharmaceuticals, INC. | $34.58 | 2025 | Purified Cortrophin Gel |
| Pfizer INC. | $27.55 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $27.13 | 2025 | Hyqvia |
| Biogen, INC. | $23.69 | 2025 | Vumerity, Tysabri |
| Lilly USA, LLC | $22.87 | 2025 | Kisunla |
| Neurelis, INC. | $19.41 | 2025 | Valtoco |
| Sk Life Science, INC. | $17.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luchane Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.